BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 20570189)

  • 1. Evaluation of clinico-pathological criteria and the Ki67 index as prognostic indicators in canine insulinoma.
    Buishand FO; Kik M; Kirpensteijn J
    Vet J; 2010 Jul; 185(1):62-7. PubMed ID: 20570189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of prognostic indicators using validated canine insulinoma tissue microarrays.
    Buishand FO; Visser J; Kik M; Gröne A; Keesler RI; Briaire-de Bruijn IH; Kirpensteijn J
    Vet J; 2014 Jul; 201(1):57-63. PubMed ID: 24878267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. KI67 proliferation index in tumors of the upper urinary tract as related to established prognostic factors and long-term survival.
    Rey A; Lara PC; Redondo E; Valdés E; Apolinario R
    Arch Esp Urol; 1998 Mar; 51(2):204-10. PubMed ID: 9586325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved histologic and clinicopathologic criteria for prognostic evaluation of pancreatic endocrine tumors.
    La Rosa S; Klersy C; Uccella S; Dainese L; Albarello L; Sonzogni A; Doglioni C; Capella C; Solcia E
    Hum Pathol; 2009 Jan; 40(1):30-40. PubMed ID: 18715612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PCNA and Ki67 proliferation markers as criteria for prediction of clinical behaviour of melanocytic tumours in cats and dogs.
    Roels S; Tilmant K; Ducatelle R
    J Comp Pathol; 1999 Jul; 121(1):13-24. PubMed ID: 10373290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic evaluation of Ki67 threshold value in canine oral melanoma.
    Bergin IL; Smedley RC; Esplin DG; Spangler WL; Kiupel M
    Vet Pathol; 2011 Jan; 48(1):41-53. PubMed ID: 21123859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MIB-1 labelling indices according to clinico-pathological variables in canine mammary tumours: a multivariate study.
    De Matos AJ; Lopes CC; Faustino AM; Carvalheira JG; Dos Santos MS; Rutteman GR; Gärtner Mde F
    Anticancer Res; 2006; 26(3A):1821-6. PubMed ID: 16827113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic factors and survival in 324 patients with pancreatic endocrine tumor treated at a single institution.
    Ekeblad S; Skogseid B; Dunder K; Oberg K; Eriksson B
    Clin Cancer Res; 2008 Dec; 14(23):7798-803. PubMed ID: 19047107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic and biological significance of cytokeratin 19 in pancreatic endocrine tumours.
    La Rosa S; Rigoli E; Uccella S; Novario R; Capella C
    Histopathology; 2007 Apr; 50(5):597-606. PubMed ID: 17394496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Ki67 index with prognosis for intermediate-grade canine cutaneous mast cell tumours.
    Maglennon GA; Murphy S; Adams V; Miller J; Smith K; Blunden A; Scase TJ
    Vet Comp Oncol; 2008 Dec; 6(4):268-74. PubMed ID: 19178685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA copy number status is a powerful predictor of poor survival in endocrine pancreatic tumor patients.
    Jonkers YM; Claessen SM; Perren A; Schmitt AM; Hofland LJ; de Herder W; de Krijger RR; Verhofstad AA; Hermus AR; Kummer JA; Skogseid B; Volante M; Voogd AC; Ramaekers FC; Speel EJ
    Endocr Relat Cancer; 2007 Sep; 14(3):769-79. PubMed ID: 17914106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Malignant ileocaecal serotonin-producing carcinoid tumours: the presence of a solid growth pattern and/or Ki67 index above 1% identifies patients with a poorer prognosis.
    Cunningham JL; Grimelius L; Sundin A; Agarwal S; Janson ET
    Acta Oncol; 2007; 46(6):747-56. PubMed ID: 17653896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression and prognostic significance of CK19 in canine malignant mammary tumours.
    Gama A; Alves A; Schmitt F
    Vet J; 2010 Apr; 184(1):45-51. PubMed ID: 19264518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulinoma in dogs: a review.
    Goutal CM; Brugmann BL; Ryan KA
    J Am Anim Hosp Assoc; 2012; 48(3):151-63. PubMed ID: 22474047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Insulinoma].
    de Boer HH
    Ned Tijdschr Geneeskd; 1982 Aug; 126(34):1529-31. PubMed ID: 6290907
    [No Abstract]   [Full Text] [Related]  

  • 16. Improved survival in a retrospective cohort of 28 dogs with insulinoma.
    Polton GA; White RN; Brearley MJ; Eastwood JM
    J Small Anim Pract; 2007 Mar; 48(3):151-6. PubMed ID: 17355606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chromogranin A plasma concentration and expression in pancreatic islet cell tumors of dogs and cats.
    Myers NC; Andrews GA; Chard-Bergstrom C
    Am J Vet Res; 1997 Jun; 58(6):615-20. PubMed ID: 9185968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pancreatic insulin-secreting neoplasm (insulinoma) in a West Highland white terrier.
    Cox D
    Can Vet J; 1999 May; 40(5):343-5. PubMed ID: 10340097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. It's time to unamend the insulin-glucose ratio.
    Edwards DF
    J Am Vet Med Assoc; 1986 May; 188(9):951-3. PubMed ID: 3011720
    [No Abstract]   [Full Text] [Related]  

  • 20. The amended insulin-glucose ratio. Is it really better?
    Knowlen GG; Schall WD
    J Am Vet Med Assoc; 1984 Aug; 185(4):397-9. PubMed ID: 6088454
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.